Q2 2023 Pharmacy & Infusion Services Update
In Q2-2023, healthcare providers continued expanding upon their home infusion service lines as site-of-care strategies grow in importance. The COVID-19 pandemic increased demand for home-based care, boosting growth in the home infusion therapy sector. Home infusion therapy offers various benefits including convenience, cost-effectiveness, better outcomes, and higher safety standards.
Provident anticipates that deal flow will remain high as healthcare systems continue to invest in home infusion service lines.
Sellers seeking M&A opportunities to either exit their ownership positions or find a strategic partner to drive growth are positioned to benefit from this continued investor interest and a growing community of well-financed, growth-oriented buyers.
To print and download the full Pharmacy & Infusion Services Update report, please click below…
[holo_button icon=”/wp-content/uploads/2023/07/Q2-2023-Newsletter-Package_Pharmacy-Infusion.pdf” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]